THL – TorHoerman Law

FDA requires new physician labels for Levaquin


The FDA requires new safety information with the use of Levaquin, particularly the increased risks of tendonitis and tendon rupture. Read about the new requirements here.

No Comments Posted

Leave a Reply

Your email address will not be published. Required fields are marked *

« Read more related news

Filter News

No-Obligation Free Consultation

Contact us by phone at (618) 656-4400 or email us below.

Sidebar Contact